Aspiration Pneumonia
35
6
6
17
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
8.6%
3 terminated out of 35 trials
85.0%
-1.5% vs benchmark
20%
7 trials in Phase 3/4
18%
3 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (35)
Gastric POCUS for Airway Management in Patients Using Glucagon-like Peptide-1 Receptor Agonist (Multicentric)
Continuous Enteral Feeding Until Tracheostomy and Aspiration Risk
Gastric Assessment of Pediatric Patients Undergoing Surgery
Effect of Oral Hygiene Care on Prevention of Aspiration Pneumonia Among Hospitalized Stroke Patients
Early Antibiotics After Aspiration in ICU Patients
Gastrointestinal Dysmotility on Aspiration Risk
Early Stop(Ruling) of the Antibiotic Treatment During Pneumopathies d' Inhalation
Potential Biomarkers and Pathogenic Mechanism for Reflux Aspiration-induced Lung Injury.
Nutrition Monitoring and Feeding Optimization With the smART+ System - Comparative Study
Aspiration Pneumonia in Cerebrovascular Stroke Patients Suffering from Bulbar Palsy
Slow-Stream Expiratory Muscle Strength Training for Veterans With Dysphagia Living in Long-term Care
FBS-ASaP: Fibrobronchoscopy in ASpiration Pneumonia in the Emergency Department
Gastric US in ICU Patient
The Cricoid Pressure in Pediatric Patients
Community Acquired Pneumonia in Older Adults
Eating Rehabilitation Training for Timely Removal of Nasogastric Tube in Elderly Patients
Nocturnal Nasal Continuous Positive Airway Pressure in Aspiration Pneumonia
Functionality and Accuracy of the smART System in Real-Life ICU Settings
Avoiding Neuromuscular Blockers to Reduce Complications
Dynamic Laryngotracheal Separation for Aspiration